Literature DB >> 29409671

Spatial interaction of tumor cells and regulatory T cells correlates with survival in non-small cell lung cancer.

Souptik Barua1, Penny Fang2, Amrish Sharma3, Junya Fujimoto4, Ignacio Wistuba4, Arvind U K Rao5, Steven H Lin6.   

Abstract

OBJECTIVES: To determine the prognostic significance of spatial proximity of lung cancer cells and specific immune cells in the tumor microenvironment.
MATERIALS AND METHODS: We probed formalin-fixed, paraffin-embedded (FFPE) tissue microarrays using a novel tyramide signal amplification multiplexing technique labelling CD8, CD4, Foxp3, and CD68+ cells. Each multiplex stained immunohistochemistry slide was digitally processed by Vectra INFORMS software, and an X- and Y-coordinate assigned to each labeled cell type. The abundance and spatial location of each cell type and their proximity to one another was analyzed using a novel application of the G-cross spatial distance distribution method which computes the probability of finding at least one immune cell of any given type within a rμm radius of a tumor cell. Cox proportional hazards multiple regression was used for multivariate analysis of the influence of proximity of lymphocyte types.
RESULTS: Pathologic tumor specimens from 120 NSCLC patients with pathologic tumor stage I-III disease were analyzed. On univariate analysis, age (P = .0007) and number of positive nodes (P = .0014) were associated with overall survival. Greater area under the curve (AUC) of the G-cross function for tumor cell-Treg interactions was significantly associated with worse survival adjusting for age and number of positive nodes (HR 1.52 (1.11-2.07), P = .009). Greater G-cross AUC for T-reg-CD8 was significantly associated with better survival adjusting for age and number of positive lymph nodes (HR 0.96 (0.92-0.99), P = .042).
CONCLUSION: Increased infiltration of regulatory T cells into core tumor regions is an independent predictor of worse overall survival in NSCLC. However, increased infiltration of CD8+ cytotoxic T cells among regulatory T cells seems to mitigate this effect and was significantly associated with better survival. Validation of the G-cross method of measuring spatial proximity between tumor and immune cell types and exploration of its use as a prognostic factor in lung cancer treatment is warranted.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Immune cells; Intratumoral T cells; Non-small cell lung cancer; Spatial computation; Spatial distances; T regulatory cells

Mesh:

Year:  2018        PMID: 29409671      PMCID: PMC6294443          DOI: 10.1016/j.lungcan.2018.01.022

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  37 in total

1.  Prognostic value of tumor-infiltrating CD4+ T-cell subpopulations in head and neck cancers.

Authors:  Cécile Badoual; Stéphane Hans; José Rodriguez; Severine Peyrard; Christophe Klein; Nour El Houda Agueznay; Véronique Mosseri; Ollivier Laccourreye; Patrick Bruneval; Wolf H Fridman; Daniel F Brasnu; Eric Tartour
Journal:  Clin Cancer Res       Date:  2006-01-15       Impact factor: 12.531

2.  Prognostic value of arginase-II expression and regulatory T-cell infiltration in head and neck squamous cell carcinoma.

Authors:  Luc Bron; Camilla Jandus; Snezana Andrejevic-Blant; Daniel E Speiser; Philippe Monnier; Pedro Romero; Jean-Paul Rivals
Journal:  Int J Cancer       Date:  2012-10-03       Impact factor: 7.396

3.  Prognostic Role of Tumor-Infiltrating Lymphocytes in Lung Cancer: a Meta-Analysis.

Authors:  Yiting Geng; Yingjie Shao; Wenting He; Wenwei Hu; Yanjie Xu; Jun Chen; Changping Wu; Jingting Jiang
Journal:  Cell Physiol Biochem       Date:  2015-10-30

Review 4.  The role of tumor-infiltrating immune cells and chronic inflammation at the tumor site on cancer development, progression, and prognosis: emphasis on non-small cell lung cancer.

Authors:  Roy M Bremnes; Khalid Al-Shibli; Tom Donnem; Rafael Sirera; Samer Al-Saad; Sigve Andersen; Helge Stenvold; Carlos Camps; Lill-Tove Busund
Journal:  J Thorac Oncol       Date:  2011-04       Impact factor: 15.609

Review 5.  The immune contexture in human tumours: impact on clinical outcome.

Authors:  Wolf Herman Fridman; Franck Pagès; Catherine Sautès-Fridman; Jérôme Galon
Journal:  Nat Rev Cancer       Date:  2012-03-15       Impact factor: 60.716

6.  Prevalence of FOXP3+ regulatory T cells increases during the progression of pancreatic ductal adenocarcinoma and its premalignant lesions.

Authors:  Nobuyoshi Hiraoka; Kaoru Onozato; Tomoo Kosuge; Setsuo Hirohashi
Journal:  Clin Cancer Res       Date:  2006-09-15       Impact factor: 12.531

Review 7.  How regulatory T cells work.

Authors:  Dario A A Vignali; Lauren W Collison; Creg J Workman
Journal:  Nat Rev Immunol       Date:  2008-07       Impact factor: 53.106

8.  Differential expression of granzymes A and B in human cytotoxic lymphocyte subsets and T regulatory cells.

Authors:  William J Grossman; James W Verbsky; Benjamin L Tollefsen; Claudia Kemper; John P Atkinson; Timothy J Ley
Journal:  Blood       Date:  2004-07-06       Impact factor: 22.113

9.  Improved computer-assisted analysis of the global lymphatic network in human cervical tissues.

Authors:  Cédric Balsat; Nicolas Signolle; Frédéric Goffin; Katty Delbecque; Benoit Plancoulaine; Philippe Sauthier; Vanessa Samouëlian; Aude Béliard; Carine Munaut; Jean-Michel Foidart; Silvia Blacher; Agnès Noël; Frédéric Kridelka
Journal:  Mod Pathol       Date:  2013-12-06       Impact factor: 7.842

Review 10.  Towards the introduction of the 'Immunoscore' in the classification of malignant tumours.

Authors:  Jérôme Galon; Bernhard Mlecnik; Gabriela Bindea; Helen K Angell; Anne Berger; Christine Lagorce; Alessandro Lugli; Inti Zlobec; Arndt Hartmann; Carlo Bifulco; Iris D Nagtegaal; Richard Palmqvist; Giuseppe V Masucci; Gerardo Botti; Fabiana Tatangelo; Paolo Delrio; Michele Maio; Luigi Laghi; Fabio Grizzi; Martin Asslaber; Corrado D'Arrigo; Fernando Vidal-Vanaclocha; Eva Zavadova; Lotfi Chouchane; Pamela S Ohashi; Sara Hafezi-Bakhtiari; Bradly G Wouters; Michael Roehrl; Linh Nguyen; Yutaka Kawakami; Shoichi Hazama; Kiyotaka Okuno; Shuji Ogino; Peter Gibbs; Paul Waring; Noriyuki Sato; Toshihiko Torigoe; Kyogo Itoh; Prabhu S Patel; Shilin N Shukla; Yili Wang; Scott Kopetz; Frank A Sinicrope; Viorel Scripcariu; Paolo A Ascierto; Francesco M Marincola; Bernard A Fox; Franck Pagès
Journal:  J Pathol       Date:  2014-01       Impact factor: 7.996

View more
  48 in total

1.  Tumor cellular proliferation is associated with enhanced immune checkpoint expression in stage I non-small cell lung cancer.

Authors:  Kyle G Mitchell; Edwin R Parra; David B Nelson; Jiexin Zhang; Ignacio I Wistuba; Junya Fujimoto; Jack A Roth; Mara B Antonoff
Journal:  J Thorac Cardiovasc Surg       Date:  2019-05-17       Impact factor: 5.209

2.  B7-H3 Expression in Merkel Cell Carcinoma-Associated Endothelial Cells Correlates with Locally Aggressive Primary Tumor Features and Increased Vascular Density.

Authors:  Phyu P Aung; Edwin Roger Parra; Souptik Barua; Dawen Sui; Jing Ning; Barbara Mino; Debora Alejandra Ledesma; Jonathan L Curry; Priyadharsini Nagarajan; Carlos A Torres-Cabala; Eleni Efstathiou; Anh G Hoang; Michael K Wong; Jennifer A Wargo; Alexander J Lazar; Arvind Rao; Victor G Prieto; Ignacio Wistuba; Michael T Tetzlaff
Journal:  Clin Cancer Res       Date:  2019-02-26       Impact factor: 12.531

Review 3.  Report on computational assessment of Tumor Infiltrating Lymphocytes from the International Immuno-Oncology Biomarker Working Group.

Authors:  Mohamed Amgad; Elisabeth Specht Stovgaard; Eva Balslev; Jeppe Thagaard; Weijie Chen; Sarah Dudgeon; Ashish Sharma; Jennifer K Kerner; Carsten Denkert; Yinyin Yuan; Khalid AbdulJabbar; Stephan Wienert; Peter Savas; Leonie Voorwerk; Andrew H Beck; Anant Madabhushi; Johan Hartman; Manu M Sebastian; Hugo M Horlings; Jan Hudeček; Francesco Ciompi; David A Moore; Rajendra Singh; Elvire Roblin; Marcelo Luiz Balancin; Marie-Christine Mathieu; Jochen K Lennerz; Pawan Kirtani; I-Chun Chen; Jeremy P Braybrooke; Giancarlo Pruneri; Sandra Demaria; Sylvia Adams; Stuart J Schnitt; Sunil R Lakhani; Federico Rojo; Laura Comerma; Sunil S Badve; Mehrnoush Khojasteh; W Fraser Symmans; Christos Sotiriou; Paula Gonzalez-Ericsson; Katherine L Pogue-Geile; Rim S Kim; David L Rimm; Giuseppe Viale; Stephen M Hewitt; John M S Bartlett; Frédérique Penault-Llorca; Shom Goel; Huang-Chun Lien; Sibylle Loibl; Zuzana Kos; Sherene Loi; Matthew G Hanna; Stefan Michiels; Marleen Kok; Torsten O Nielsen; Alexander J Lazar; Zsuzsanna Bago-Horvath; Loes F S Kooreman; Jeroen A W M van der Laak; Joel Saltz; Brandon D Gallas; Uday Kurkure; Michael Barnes; Roberto Salgado; Lee A D Cooper
Journal:  NPJ Breast Cancer       Date:  2020-05-12

4.  Multiplex Immunofluorescence Histology for Immune Cell Infiltrates in Melanoma-Associated Tertiary Lymphoid Structures.

Authors:  Ileana S Mauldin; Adela Mahmutovic; Samuel J Young; Craig L Slingluff
Journal:  Methods Mol Biol       Date:  2021

5.  Poor Response to Neoadjuvant Chemotherapy Correlates with Mast Cell Infiltration in Inflammatory Breast Cancer.

Authors:  Naoto T Ueno; Savitri Krishnamurthy; Jennifer A Wargo; Elizabeth A Mittendorf; Sangeetha M Reddy; Alexandre Reuben; Souptik Barua; Hong Jiang; Shaojun Zhang; Linghua Wang; Vancheswaran Gopalakrishnan; Courtney W Hudgens; Michael T Tetzlaff; James M Reuben; Takahiro Tsujikawa; Lisa M Coussens; Khalida Wani; Yan He; Lily Villareal; Anita Wood; Arvind Rao; Wendy A Woodward
Journal:  Cancer Immunol Res       Date:  2019-05-01       Impact factor: 11.151

6.  Prognostic Significance of Immune Cell Populations Identified by Machine Learning in Colorectal Cancer Using Routine Hematoxylin and Eosin-Stained Sections.

Authors:  Juha P Väyrynen; Mai Chan Lau; Koichiro Haruki; Sara A Väyrynen; Jeffrey A Meyerhardt; Marios Giannakis; Shuji Ogino; Jonathan A Nowak; Andressa Dias Costa; Jennifer Borowsky; Melissa Zhao; Kenji Fujiyoshi; Kota Arima; Tyler S Twombly; Junko Kishikawa; Simeng Gu; Saina Aminmozaffari; Shanshan Shi; Yoshifumi Baba; Naohiko Akimoto; Tomotaka Ugai; Annacarolina Da Silva; Mingyang Song; Kana Wu; Andrew T Chan; Reiko Nishihara; Charles S Fuchs
Journal:  Clin Cancer Res       Date:  2020-05-21       Impact factor: 12.531

7.  Deconvolution of the immunological contexture of mouse tumors with multiplexed immunohistochemistry.

Authors:  Ileana S Mauldin; Natasha D Sheybani; Samuel J Young; Richard J Price; Craig L Slingluff
Journal:  Methods Enzymol       Date:  2019-06-29       Impact factor: 1.600

8.  Tumour immune microenvironment in resected thymic carcinomas as a predictor of clinical outcome.

Authors:  Giovanni Bocchialini; Ana-Iris Schiefer; Leonhard Müllauer; Jürgen Thanner; Jonas Bauer; Felizia Thaler; Maria Laggner; Cecilia Veraar; Walter Klepetko; Konrad Hötzenecker; José Ramon Matilla; Hendrik Jan Ankersmit; Bernhard Moser
Journal:  Br J Cancer       Date:  2022-06-24       Impact factor: 9.075

Review 9.  Spatial architecture of the immune microenvironment orchestrates tumor immunity and therapeutic response.

Authors:  Tong Fu; Lei-Jie Dai; Song-Yang Wu; Yi Xiao; Ding Ma; Yi-Zhou Jiang; Zhi-Ming Shao
Journal:  J Hematol Oncol       Date:  2021-06-25       Impact factor: 17.388

Review 10.  Challenges and Opportunities in the Statistical Analysis of Multiplex Immunofluorescence Data.

Authors:  Christopher M Wilson; Oscar E Ospina; Mary K Townsend; Jonathan Nguyen; Carlos Moran Segura; Joellen M Schildkraut; Shelley S Tworoger; Lauren C Peres; Brooke L Fridley
Journal:  Cancers (Basel)       Date:  2021-06-17       Impact factor: 6.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.